FindTrial
Sign In

D2 radical gastrectomy

PROCEDURE4 trials

Sponsors

Wuhan University, Shanghai Zhongshan Hospital

Conditions

Gastric / Gastroesophageal Junction AdenocarcinomaGastric AdenocarcinomaGastroesophageal AdenocarcinomaImmunotherapyMalignant Neoplasm of StomachMismatch Repair Deficient or MSI-High Solid Tumors

Phase 2

Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
CompletedNCT02528110
Wuhan UniversityMalignant Neoplasm of Stomach
Start: 2015-08-31End: 2020-03-10Updated: 2020-03-24
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
NCT04345770
Wuhan UniversityMalignant Neoplasm of Stomach
Start: 2020-04-01End: 2025-05-31Target: 100Updated: 2020-04-14
Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma
Not yet recruitingNCT07259473
Shanghai Zhongshan HospitalGastric / Gastroesophageal Junction Adenocarcinoma, Immunotherapy, Mismatch Repair Deficient or MSI-High Solid Tumors
Start: 2026-01-31End: 2029-12-30Target: 15Updated: 2026-01-07
Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study
Not yet recruitingNCT07266025
Shanghai Zhongshan HospitalGastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Immunotherapy +1
Start: 2026-01-30End: 2030-06-30Target: 30Updated: 2026-01-27

Related Papers

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial
Journal of Clinical Oncology2023-10-31107 citations